The Association Between Delivered Oxygen and Cerebral Impact During the Use of Cardiopulmonary Bypass.
1 other identifier
observational
106
1 country
1
Brief Summary
Investigating the connection between delivered oxygen index and cerebral impact with COx (cerebral oximetry index) och cerebral injury markers during the routine use of cardiopulmonary bypass.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2022
CompletedFirst Posted
Study publicly available on registry
November 17, 2022
CompletedStudy Start
First participant enrolled
January 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2025
CompletedMay 30, 2025
May 1, 2025
2 years
November 2, 2022
May 26, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
COx
COx (Cerebral Oximetry Index; correlation between rSO2 values (INVOS) and mean artery pressure) that indicated impact on cerebral autoregulation on DO2 index values below set limits of 280 ml/m2/min.
24 hours
Brain injury markers; tau, GFAP, NSE
Brain injury markers that indicate cerebral neuronal damage on DO2 index values below set limits of 280 ml/m2/min.
96 hours
Study Arms (2)
Group with DO2i <280 ml/min/m2 during cardiopulmonary bypass
Group with DO2i >280 ml/min/m2 during cardiopulmonary bypass
Interventions
Blood tests at given time points perioperatively.
Cerebral oximetry index measurements with the aid of Near Infrared Spectroscopy
Eligibility Criteria
120 research subjects scheduled for coronary arterial bypass grafting surgery and/or aortic valve replacement in Uppsala University Hospital.
You may qualify if:
- Patients scheduled for CABG and/or AVR
You may not qualify if:
- Former diagnosed neurological insults, carotid stenosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Uppsala University Hospitalcollaborator
Study Sites (1)
Uppsala University Hospital
Uppsala, Uppsala County, 75135, Sweden
Biospecimen
Cerebral injury markers in blood plasma
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karl-Henrik Grinnemo, Adj. Prof.
Uppsala University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2022
First Posted
November 17, 2022
Study Start
January 2, 2023
Primary Completion
January 4, 2025
Study Completion
January 4, 2025
Last Updated
May 30, 2025
Record last verified: 2025-05